0000899243-22-028395.txt : 20220811 0000899243-22-028395.hdr.sgml : 20220811 20220811170754 ACCESSION NUMBER: 0000899243-22-028395 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20220809 FILED AS OF DATE: 20220811 DATE AS OF CHANGE: 20220811 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RIGGS RORY B CENTRAL INDEX KEY: 0001016835 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39329 FILM NUMBER: 221156861 MAIL ADDRESS: STREET 1: 65 RAILROAD AVE CITY: RIDGEFIELD STATE: NJ ZIP: 07657 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Royalty Pharma plc CENTRAL INDEX KEY: 0001802768 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 110 EAST 59TH STREET CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: (212) 883-0200 MAIL ADDRESS: STREET 1: 110 EAST 59TH STREET CITY: NEW YORK STATE: NY ZIP: 10022 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-08-09 0 0001802768 Royalty Pharma plc RPRX 0001016835 RIGGS RORY B C/O ROYALTY PHARMA PLC 110 E. 59TH STREET NEW YORK NY 10022 1 0 0 0 Class A Ordinary Shares 2022-08-09 4 S 0 45000 43.7294 D 376712 D Class A Ordinary Shares 85187 I By New Ventures III LLC Class A Ordinary Shares 15000 I By Spouse The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.66 to $43.80 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Exhibit List - Exhibit 24.1 - Power of Attorney /s/ Sean Weisberg, as Attorney-in-Fact for Rory B. Riggs 2022-08-11 EX-24.1 2 attachment1.htm EX-24.1 DOCUMENT

                                                                    Exhibit 24.1
                               POWER OF ATTORNEY

Know all by these presents, that the undersigned hereby constitutes and appoints
each of George Lloyd, Jason Mehar, Sean Weisberg and Jacqueline Ostendorf as the
undersigned's true and lawful attorneys-in-fact to:


     (1)   execute for and on behalf of the undersigned, in the undersigned's
           capacity as a reporting person pursuant to Section 16 of the
           Securities Exchange Act of 1934, as amended (the "Exchange Act"),
           and the rules thereunder of Royalty Pharma plc (the "Company"), Forms
           3, 4 and 5, including any amendments thereto, in accordance with
           Section 16(a) of the Exchange Act;

     (2)   do and perform any and all acts for and on behalf of the undersigned
           which may be necessary or desirable to complete and execute any such
           Form 3, 4 or 5, complete and execute any amendment or amendments
           thereto and timely file such form with the United States Securities
           and Exchange Commission and the applicable stock exchange or similar
           authority; and

     (3)   take any other action of any type whatsoever in connection with the
           foregoing which, in the opinion of any of such attorneys-in-fact,
           may be of benefit to, in the best interest of, or legally required
           by, the undersigned, it being understood that the documents executed
           by any of such attorneys-in-fact on behalf of the undersigned
           pursuant to this Power of Attorney shall be in such form and shall
           contain such terms and conditions as any of such attorneys-in-fact
           may approve in the discretion of any of such attorneys-in-fact.

The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary, or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might or
could do if personally present, with full power of substitution or revocation,
hereby ratifying and confirming all that any of such attorneys-in-fact, or the
substitute or substitutes of any of such attorneys-in-fact, shall lawfully do or
cause to be done by virtue of this Power of Attorney and the rights and powers
herein granted. The undersigned acknowledges that the foregoing
attorneys-in-fact, in serving in such capacity at the request of the
undersigned, are not assuming, nor is the Company assuming, any of the
undersigned's responsibilities to comply with Section 16 of the Exchange Act.

This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4 and 5 with respect to the
undersigned's holdings of and transactions in securities issued by the Company,
unless earlier revoked by the undersigned in a signed writing delivered to the
foregoing attorneys-in-fact.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 11th day of August, 2022.

Signature:    /s/ Rory B. Riggs
              ------------------
Print Name:   Rory B. Riggs